PRA understands how cerebrospinal fluid (CSF) sampling benefits our clients’ early phase trials. We regularly conduct CSF sampling to collect key PK and PD information necessary for clients’ go/no go decisions and to determine appropriate dosing ranges in Phase II studies.
Explore related content and topics
Poster
A Blueprint to Success: Onboarding a Medical Writer
Onboarding is the process of welcoming new employees into an organization and providing them with the tools, resources, and knowledge to become…
View Resource
White Paper
Human ADME Studies With Radiolabeled Compounds Phase I-IIa
Radiolabeled medication is widely used in the assessment of human ADME and also increasingly in assessing absolute bioavailability (BA). Conducting…
View Resource
White Paper
Favorable Regulatory Procedures In The Netherlands Phase I-IIa
The EU Clinical Trials Directive (CTD) has been fully implemented in The Netherlands. Prior to beginning a clinical trial, an identical Clinical…
View Resource
View all related content and resources for Clinical Pharmacology
Explore Insights